5-Bromo-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95+%, 100mg

4-Bromo-5-fluoro-2-methoxybenzaldehyde, 98%, 5g

6-Methyl-5H-pyrrolo[3,2-b]pyrazine, 98%, 1g

2,3-Dihydro-[1,4]oxazine-4-carbaldehyde, 98.0%, 5g

8-Methylpyrido[2,3-b]pyrazine, 95.0%, 1g

ethyl (2-amino-4-methyl-1,3-thiazol-5-yl)acetate, 95.0%, 5g

3-ethyl-2-piperazinone hydrate, 95.0%, 1g

(3-Bromo-4-chlorophenyl)methanamine, 95.0%, 25g

1-Boc-4-(carboxy-naphthalen-2-yl-methyl)-[1,4]diazepane, 96%, 5g

4-(4-tert-butylbenzoyl)-8-methyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

2-Ethoxyethyl 4-methylbenzene-1-sulfonate, 95+%, 10g

valerenic acid, with analyt. Documents, 100 mg, glass packaging

2-Fluoro-3-(trifluoromethyl)benzyl bromide, 98.0%, 25g